Kenji Kitazato

A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells

Tomohiro Emura, Yuko Murakami, Fumio Nakagawa et al. · International Journal of Molecular Medicine · 2004 · 105 citations

Medicine, Oncology, Pharmacology +15

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

Keishiro Tomoda, Takumi Ohkoshi, Keiji Hirota et al. · Colloids and Surfaces B Biointerfaces · 2009 · 94 citations

Natural Sciences, Materials Engineering, Materials Science +14

An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA

Tomohiro Emura, Fumio Nakagawa, Akio Fujioka et al. · International Journal of Molecular Medicine · 2004 · 85 citations

Medicine, Oncology, Pharmacology +16

Expression of UDP‐N‐acetyl‐α‐D‐galactosamine–polypeptide galNAc N‐acetylgalactosaminyl transferase‐3 in relation to differentiation and prognosis in patients with colorectal carcinoma

Kazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama et al. · Cancer · 2002 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +17

Antithrombotic and Anticoagulant Activity of Depolymerized Fragment of the Glycosaminoglycan Extracted from Stichopus japonicus Selenka

Norihiko Suzuki, Kenji Kitazato, Junki Takamatsu et al. · Thrombosis and Haemostasis · 1991 · 61 citations

Medicine, Biochemistry, Pharmacology +17